A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
Clinical trial NCT04200066 · WITHDRAWN
Trial details
- NCT number
- NCT04200066
- Sponsor
- University of Rochester
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2023-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.